Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Shares Issued (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Shares Issued for 4 consecutive years, with $14.3 million as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 168.29% to $14.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.4 million through Dec 2025, up 90.27% year-over-year, with the annual reading at $21.4 million for FY2025, 90.27% up from the prior year.
  • Shares Issued for Q4 2025 was $14.3 million at Centessa Pharmaceuticals, up from $3.6 million in the prior quarter.
  • The five-year high for Shares Issued was $14.3 million in Q4 2025, with the low at -$405000.0 in Q3 2022.
  • Average Shares Issued over 4 years is $2.3 million, with a median of $820000.0 recorded in 2024.
  • The sharpest move saw Shares Issued crashed 82.86% in 2023, then surged 6583.33% in 2024.
  • Over 4 years, Shares Issued stood at -$405000.0 in 2022, then surged by 129.14% to $118000.0 in 2023, then skyrocketed by 4427.12% to $5.3 million in 2024, then surged by 168.29% to $14.3 million in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $14.3 million, $3.6 million, and $1.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.